Skip to main content Accessibility help
×
Home
  • Print publication year: 2011
  • Online publication date: June 2011

Chapter 16 - Intracranial and head and neck tumors: embolization and chemotherapy

References

1. QureshiAI. Endovascular treatment of cerebrovascular diseases and intracranial neoplasms. Lancet 2004;363:804–13.
2. GounisMJ, LieberBB, WebsterKA, WakhlooAK. A novel angiographic methodology for the quantification of angiogenesis. IEEE Trans Biomed Eng 2008;55:996–1003.
3. MichaelyHJ, HerrmannKA, DietrichO, ReiserMF, SchoenbergSO. Quantitative and qualitative characterization of vascularization and hemodynamics in head and neck tumors with a 3d magnetic resonance time-resolved echo-shared angiographic technique (treat)–initial results. Eur Radiol 2007;17:1101–10.
4. StrugarJG, CriscuoloGR, RothbartD, HarringtonWN. Vascular endothelial growth/permeability factor expression in human glioma specimens: Correlation with vasogenic brain edema and tumor-associated cysts. J Neurosurg 1995;83:682–9.
5. BerkmanRA, MerrillMJ, ReinholdWC, et al. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest 1993;91:153–9.
6. DvorakHF, SioussatTM, BrownLF, et al. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: Concentration in tumor blood vessels. J Exp Med 1991;174:1275–8.
7. VlodavskyI, ElkinM, Abboud-JarrousG, et al. Heparanase: one molecule with multiple functions in cancer progression. Connect Tissue Res 2008;49:207–10.
8. VlodavskyI, IlanN, NadirY, et al. Heparanase, heparin and the coagulation system in cancer progression. Thromb Res 2007;120 Suppl 2:S112–20.
9. AharinejadS, SioudM, LucasT, AbrahamD. Target validation using rna interference in solid tumors. Methods Mol Biol 2007;361:227–38.
10. OhtaM, KitadaiY, TanakaS, et al. Monocyte chemoattractant protein-1 expression correlates with macrophage infiltration and tumor vascularity in human gastric carcinomas. Int J Oncol 2003;22:773–8.
11. McKenzieS, SakamotoS, KyprianouN. Maspin modulates prostate cancer cell apoptotic and angiogenic response to hypoxia via targeting akt. Oncogene 2008;27:7171–9.
12. CoxC, TeknosTN, BarriosM, BrewerGJ, DickRD, MerajverSD. The role of copper suppression as an antiangiogenic strategy in head and neck squamous cell carcinoma. Laryngoscope 2001;111:696–701.
13. HassounehB, IslamM, NagelT, PanQ, MerajverSD, TeknosTN. Tetrathiomolybdate promotes tumor necrosis and prevents distant metastases by suppressing angiogenesis in head and neck cancer. Mol Cancer Ther 2007;6:1039–45.
14. MowlaviA, MalafaMP. Angiogenesis in primary tumor cells of metastatic and nonmetastatic malignant melanoma. Plast Reconstr Surg 2000;106:514.
15. LongDM. Vascular ultrastructure in human meningiomas and schwannomas. J Neurosurg 1973;38:409–19.
16. CastilloM, ThompsonJE, MukherjiSK. Association of an intracranial arteriovenous malformation and a meningioma. Neuroradiology 1998;40:574–6.
17. SoriaE, FineE, HajduI. Association of intracranial meningioma with arteriovenous malformation. Surg Neurol 1990;34:111–17.
18. MaierH, OfnerD, HittmairA, KitzK, BudkaH. Classic, atypical, and anaplastic meningioma: Three histopathological subtypes of clinical relevance. J Neurosurg 1992;77:616–23.
19. MaiuriF, IaconettaG, de DivitiisO, CirilloS, Di SalleF, De CaroML. Intracranial meningiomas: Correlations between mr imaging and histology. Eur J Radiol 1999;31:69–75.
20. BlackPM. Meningiomas. Neurosurgery 1993;32:643–57.
21. TatagibaM, MirzaiS, SamiiM. Peritumoral blood flow in intracranial meningiomas. Neurosurgery 1991;28:400–4.
22. EngelhardHH. Progress in the diagnosis and treatment of patients with meningiomas. Part i: Diagnostic imaging, preoperative embolization. Surg Neurol 2001;55:89–101.
23. ServoA, PorrasM, JaaskelainenJ, PaetauA, HaltiaM. Computed tomography and angiography do not reliably discriminate malignant meningiomas from benign ones. Neuroradiology 1990;32:94–7.
24. LeeKF, LinSR, WhiteleyWH, TsaiFY, ThompsonNL, Jr., SuhJH. Angiographic findings in recurrent meningioma. Radiology 1976;119:131–9.
25. BitzerM, OpitzH, PoppJ, et al. Angiogenesis and brain oedema in intracranial meningiomas: Influence of vascular endothelial growth factor. Acta Neurochir (Wien) 1998;140:333–40.
26. AdachiK, KawaseT, YoshidaK, YazakiT, OnozukaS. Abc surgical risk scale for skull base meningioma: A new scoring system for predicting the extent of tumor removal and neurological outcome. J Neurosurg 2009; 111: 1053–61.
27. IldanF, TunaM, GocerAP, et al. Correlation of the relationships of brain-tumor interfaces, magnetic resonance imaging, and angiographic findings to predict cleavage of meningiomas. J Neurosurg 1999;91:384–90.
28. SalpietroFM, AlafaciC, LucernaS, IacopinoDG, TodaroC, TomaselloF. Peritumoral edema in meningiomas: Microsurgical observations of different brain tumor interfaces related to computed tomography. Neurosurgery 1994;35:638–41; discussion 641–2.
29. SindouMP, AlaywanM. Most intracranial meningiomas are not cleavable tumors: Anatomic-surgical evidence and angiographic predictibility. Neurosurgery 1998;42:476–80.
30. BitzerM, WockelL, LuftAR, et al. The importance of pial blood supply to the development of peritumoral brain edema in meningiomas. J Neurosurg 1997;87:368–73.
31. SmithHP, ChallaVR, MoodyDM, KellyDL, Jr. Biological features of meningiomas that determine the production of cerebral edema. Neurosurgery 1981;8:428–33.
32. SatoM, MatsumotoM, KodamaN. [treatment of skull base meningioma encasing the main cerebral artery]. No Shinkei Geka 1997;25:239–45.
33. IshikawaM, NishiS, AokiT, et al. Predictability of internal carotid artery (ica) dissectability in cases showing ica involvement in parasellar meningioma. J Clin Neurosci 2001;8 Suppl 1:22–5.
34. HiyamaH, KuboO, TajikaY, TohyamaT, TakakuraK. Meningiomas associated with peritumoural venous stasis: Three types on cerebral angiogram. Acta Neurochir (Wien) 1994;129:31–8.
35. GoodCD, KingsleyDP, TaylorWJ, HarknessWF. “Dural tail” Adjacent to a giant posterior cerebral artery aneurysm: case report and review of the literature. Neuroradiology 1997;39:577–80.
36. ForbesG. Radiologic evaluation of orbital tumors. Clin Neurosurg 1985;32:474–513.
37. McDermottMW, RootmanJ, DurityFA. Subperiosteal, subperiorbital dissection and division of the anterior and posterior ethmoid arteries for meningiomas of the cribriform plate and planum sphenoidale: technical note. Neurosurgery 1995;36:1215–18; discussion 1218–19.
38. AbeT, MatsumotoK, HommaH, KawamuraN, IwataT, NemotoS. Dorsum sellae meningioma mimicking pituitary macroadenoma: case report. Surg Neurol 1999;51:543–6; discussion 546–7.
39. DonovanJL, NesbitGM. Distinction of masses involving the sella and suprasellar space: Specificity of imaging features. Am J Roentgenol 1996;167:597–603.
40. NozakiK, NagataI, YoshidaK, KikuchiH. Intrasellar meningioma: Case report and review of the literature. Surg Neurol 1997;47:447–452; discussion 452–4.
41. TeradaT, KinoshitaY, YokoteH, et al. Preoperative embolization of meningiomas fed by ophthalmic branch arteries. Surg Neurol 1996;45:161–6.
42. SorimachiT, MaruyaJ, MizusawaY, ItoY, TakeuchiS. Glaucoma as a complication of superselective ophthalmic angiography. Am J Neuroradiol 2003;24:1552–3.
43. BoulosPT, DumontAS, MandellJW, JaneJA, Sr. Meningiomas of the orbit: Contemporary considerations. Neurosurg Focus 2001;10:E5.
44. LefkowitzM, GiannottaSL, HieshimaG, et al. Embolization of neurosurgical lesions involving the ophthalmic artery. Neurosurgery 1998;43:1298–303.
45. SekharLN, SwamyNK, JaiswalV, RubinsteinE, HirschWE, Jr., WrightDC. Surgical excision of meningiomas involving the clivus: Preoperative and intraoperative features as predictors of postoperative functional deterioration. J Neurosurg 1994;81:860–8.
46. KusakaN, TamiyaT, SugiuK, et al. Combined use of trufill dcs detachable coil system and guglielmi detachable coil for embolization of meningioma fed by branches of the cavernous internal carotid artery. Neurol Med Chir (Tokyo) 2007;47:29–31.
47. HirohataM, AbeT, MorimitsuH, FujimuraN, ShigemoriM, NorbashAM. Preoperative selective internal carotid artery dural branch embolisation for petroclival meningiomas. Neuroradiology 2003;45:656–60.
48. TymianskiM, WillinskyRA, TatorCH, MikulisD, TerBruggeKG, MarksonL. Embolization with temporary balloon occlusion of the internal carotid artery and in vivo proton spectroscopy improves radical removal of petrous-tentorial meningioma. Neurosurgery 1994;35:974–7; discussion 977.
49. TeradaT, YokoteH, TsuuraM, et al. Presumed intraventricular meningioma treated by embolisation and the gamma knife. Neuroradiology 1999;41:334–7.
50. AsariS, MaeshiroT, TomitaS, et al. Meningiomas arising from the falcotentorial junction. Clinical features, neuroimaging studies, and surgical treatment. J Neurosurg 1995;82:726–38.
51. OdakeG. Meningioma of the falcotentorial region: Report of two cases and literature review of occlusion of the galenic system. Neurosurgery 1992;30:788–93; discussion 793–4.
52. RostomilyRC, EskridgeJM, WinnHR. Tentorial meningiomas. Neurosurg Clin N Am 1994;5:331–48.
53. Quinones-HinojosaA, ChangEF, ChaichanaKL, McDermottMW. Surgical considerations in the management of falcotentorial meningiomas: advantages of the bilateral occipital transtentorial/transfalcine craniotomy for large tumors. Neurosurgery 2009;64:260–268; discussion 268.
54. RossittiS. Preoperative embolization of lower-falx meningiomas with ethylene vinyl alcohol copolymer: technical and anatomical aspects. Acta Radiol 2007;48:321–6.
55. HarrisonMJ, WolfeDE, LauTS, MitnickRJ, SachdevVP. Radiation-induced meningiomas: experience at the mount sinai hospital and review of the literature. J Neurosurg 1991;75:564–74.
56. ManelfeC, LasjauniasP, RuscalledaJ. Preoperative embolization of intracranial meningiomas. Am J Neuroradiol 1986;7:963–72.
57. KaiY, HamadaJI, MoriokaM, et al. Clinical evaluation of cellulose porous beads for the therapeutic embolization of meningiomas. Am J Neuroradiol 2006;27:1146–50.
58. RosenCL, AmmermanJM, SekharLN, BankWO. Outcome analysis of preoperative embolization in cranial base surgery. Acta Neurochir (Wien) 2002;144:1157–64.
59. GruberA, BavinzskiG, KillerM, RichlingB. Preoperative embolization of hypervascular skull base tumors. Minim Invas Neurosurg 2000;43:62–71.
60. YamaguchiN, KawaseT, SagohM, OhiraT, ShigaH, ToyaS. Prediction of consistency of meningiomas with preoperative magnetic resonance imaging. Surg Neurol 1997;48:579–83.
61. GruberA, KillerM, MazalP, BavinzskiG, RichlingB. Preoperative embolization of intracranial meningiomas: A 17-years single center experience. Minim Invas Neurosurg 2000;43:18–29.
62. GrandC, BankWO, BaleriauxD, et al. Gadolinium-enhanced mr in the evaluation of preoperative meningioma embolization. Am J Neuroradiol 1993;14:563–9.
63. MartinAJ, ChaS, HigashidaRT, et al. Assessment of vasculature of meningiomas and the effects of embolization with intra-arterial mr perfusion imaging: a feasibility study. Am J Neuroradiol 2007;28:1771–7.
64. BrueningR, WuRH, YousryTA, et al. Regional relative blood volume mr maps of meningiomas before and after partial embolization. J Comput Assist Tomogr 1998;22:104–10.
65. MorimuraT, TakeuchiJ, MaedaY, TaniE. Preoperative embolization of meningiomas: its efficacy and histopathological findings. Noshuyo Byori 1994;11:123–9.
66. PerryA, ChicoineMR, FiliputE, MillerJP, CrossDT. Clinicopathologic assessment and grading of embolized meningiomas: a correlative study of 64 patients. Cancer 2001;92:701–11.
67. BendszusM, Warmuth-MetzM, KleinR, et al. Sequential mri and mr spectroscopy in embolized meningiomas: correlation with surgical and histopathological findings. Neuroradiology 2002;44:77–82.
68. BlankenhornM, BachertP, SemmlerW, et al. [phosphorus-31-mr spectroscopy imaging in preoperative embolization treatment of meningioma]. Rofo 1999;170:568–74.
69. JunglingFD, WakhlooAK, HennigJ. In vivo proton spectroscopy of meningioma after preoperative embolization. Magn Reson Med 1993;30:155–60.
70. PatsourisE, LaasR, HagelC, StavrouD. Increased proliferative activity due to necroses induced by pre-operative embolization in benign meningiomas. J Neurooncol 1998;40:257–64.
71. NgHK, PoonWS, GohK, ChanMS. Histopathology of post-embolized meningiomas. Am J Surg Pathol 1996;20:1224–30.
72. NakasuS, NakajimaM, NakazawaT, NakasuY, HandaJ. P53 accumulation and apoptosis in embolized meningiomas. Acta Neuropathol 1997;93:599–605.
73. NakasuS, NakajimaM, NakazawaT, NakasuY, HandaJ. Alteration of bcl-2 and bax expression in embolized meningiomas. Brain Tumor Pathol 1998;15:13–17.
74. JensenRL, SoleauS, BhayaniMK, ChristiansenD. Expression of hypoxia inducible factor-1 alpha and correlation with preoperative embolization of meningiomas. J Neurosurg 2002;97:658–67.
75. ParkK, KimJH, NamDH, et al. Vascular endothelial growth factor expression under ischemic stress in human meningiomas. Neurosci Lett 2000;283:45–8.
76. ZhangXB, JinZY. [clinical application of presurgical embolization of meningiomas]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2003;25:168–71.
77. BendszusM, RaoG, BurgerR, et al. Is there a benefit of preoperative meningioma embolization?Neurosurgery 2000;47:1306–11; discussion 1311–12.
78. OkaH, KurataA, KawanoN, et al. Preoperative superselective embolization of skull-base meningiomas: Indications and limitations. J Neurooncol 1998;40:67–71.
79. DeanBL, FlomRA, WallaceRC, et al. Efficacy of endovascular treatment of meningiomas: evaluation with matched samples. AJNR Am J Neuroradiol 1994;15:1675–80.
80. ChunJY, McDermottMW, LambornKR, WilsonCB, HigashidaR, BergerMS. Delayed surgical resection reduces intraoperative blood loss for embolized meningiomas. Neurosurgery 2002;50:1231–5; discussion 1235–7.
81. KaiY, HamadaJ, MoriokaM, YanoS, TodakaT, UshioY. Appropriate interval between embolization and surgery in patients with meningioma. Am J Neuroradiol 2002;23:139–42.
82. KuroiwaT, TanakaH, OhtaT, TsutsumiA. Preoperative embolization of highly vascular brain tumors: clinical and histopathological findings. Noshuyo Byori 1996;13:27–36.
83. BendszusM, Martin-SchraderI, SchlakeHP, SolymosiL. Embolisation of intracranial meningiomas without subsequent surgery. Neuroradiology 2003;45:451–5.
84. BendszusM, MonoranuCM, SchutzA, NolteI, VinceGH, SolymosiL. Neurologic complications after particle embolization of intracranial meningiomas. Am J Neuroradiol 2005;26:1413–19.
85. KallmesDF, EvansAJ, KaptainGJ, et al. Hemorrhagic complications in embolization of a meningioma: case report and review of the literature. Neuroradiology 1997;39:877–80.
86. SuyamaT, TamakiN, FujiwaraK, HamanoS, KimuraM, MatsumotoS. Peritumoral and intratumoral hemorrhage after gelatin sponge embolization of malignant meningioma: case report. Neurosurgery 1987;21:944–6.
87. BejjaniGK, SekharLN, YostAM, BankWO, WrightDC. Vasospasm after cranial base tumor resection: Pathogenesis, diagnosis, and therapy. Surg Neurol 1999;52:577–83; discussion 583–4.
88. GlasscockMF, JacksonCG. Neurologic skull base surgery for glomus tumors. Laryngoscope 1993;103(suppl 60):1–71.
89. MatishakMZ, SymonL, CheesemanA, PamphlettR. Catecholamine-secreting paragangliomas of the base of the skull. Report of two cases. J Neurosurg 1987;66:604–8.
90. BrackmanD, KinneyS, FuK. Glomus tumor: diagnosis and management. Head Neck Surg 1987;9:306–11.
91. MauriziM, AlmadoriG, FerriE, et al. [carotid body tumors: The clinical, diagnostic and therapeutic aspects]. Acta Otorhinolaryngol Ital 1992;12:527–45.
92. OguraJH, SpectorGJ, GadoM. Glomus jugulare and vagale. Ann Otol Rhinol Laryngol 1978;87:622–9.
93. MoretJ, PicardL.Semin Intervent Rad 1987;4:291–308.
94. TasarM, YetiserS. Glomus tumors: therapeutic role of selective embolization. J Craniofac Surg 2004;15:497–505.
95. CarmodyRF, SeegerJF, HorsleyWW, SmithJR, MillerRW. Digital subtraction angiography of glomus tympanicum and jugulare tumors. Am J Neuroradiol 1983;4:263–5.
96. GirolamiG, HeuserL, HildmannH, SudhoffH. [selective embolization and surgical resection for head and neck glomus tumours – clinical outcome analysis]. Laryngorhinootologie 2008;87:181–5.
97. MurphyTP, BrackmannDE. Effects of preoperative embolization on glomus jugulare tumors. Laryngoscope 1989;99:1244–7.
98. WardPH, LiuC, VinuelaF, BentsonJR. Embolization: An adjunctive measure for removal of carotid body tumors. Laryngoscope 1988;98:1287–91.
99. LaMuragliaGM, FabianRL, BrewsterDC, et al. The current surgical management of carotid body paragangliomas. J Vasc Surg 1992;15:1038–44; discussion 1044–5.
100. LeberKA, EustacchioS, PendlG. Radiosurgery of glomus tumors: midterm results. Stereotact Funct Neurosurg 1999;72 Suppl 1:53–9.
101. BapurajJR, ManiNB, KhandelwalNK, ThennarasuK, SharmaSC. New parameter of hemoglobin status as an indicator of efficacy of preoperative angioembolization in extracranial hypervascular tumours. J Otolaryngol 2002;31:313–16.
102. GullanePJ, DavidsonJ, O'DwyerT, ForteV. Juvenile angiofibroma: A review of the literature and a case series report. Laryngoscope 1992;102:928–33.
103. JorissenM, EloyP, RombauxP, BachertC, DaeleJ. Endoscopic sinus surgery for juvenile nasopharyngeal angiofibroma. Acta Otorhinolaryngol Belg 2000;54:201–19.
104. HarrisonDF. The natural history, pathogenesis, and treatment of juvenile angiofibroma. Personal experience with 44 patients. Arch Otolaryngol Head Neck Surg 1987;113:936–42.
105. FischU. The infratemporal fossa approach for nasopharyngeal tumors. Laryngoscope 1983;93:36–44.
106. MannWJ, JeckerP, AmedeeRG. Juvenile angiofibromas: Changing surgical concept over the last 20 years. Laryngoscope 2004;114:291–3.
107. WaldmanSR, LevineHL, AstorF, WoodBG, WeinsteinM, TuckerHM. Surgical experience with nasopharyngeal angiofibroma. Arch Otolaryngol 1981;107:677–82.
108. LasjauniasP. Nasopharyngeal angiofibromas: Hazards of embolization. Radiology 1980;136:119–23.
109. GiavroglouC, ConstantinidisJ, TriaridisS, DaniilidisJ, DimitriadisA. [angiographic evaluation and embolization of juvenile nasopharyngeal angiofibroma]. HNO 2007;55:36–41.
110. YiZ, LiZC, LinC, YeS. Huge lobulated juvenile angiofibroma: Sites of extension and selection of procedures for management. J Otolaryngol 2003;32:211–16.
111. AntonelliAR, CappielloJ, Di LorenzoD, DonajoCA, NicolaiP, OrlandiniA. Diagnosis, staging, and treatment of juvenile nasopharyngeal angiofibroma (jna). Laryngoscope 1987;97:1319–25.
112. PlatzbeckerH, KohlerK. Embolization in the head and neck region. Acta Radiol Suppl 1991;377:25–6.
113. IablonskiiSV, ShchenevSV, NikanorovA, Myl'nikov AA. [use of x-ray endovascular occlusion in combined treatment of juvenile angiofibroma of the skull base in children]. Vestn Otorinolaringol 1998:37–40.
114. De VincentiisM, GalloA, MinniA, TorriE, TomassiR, Della RoccaC. [preoperative embolization in the treatment protocol for rhinopharyngeal angiofibroma: Comparison of the effectiveness of various materials]. Acta Otorhinolaryngol Ital 1997;17:225–32.
115. GladH, VainerB, BuchwaldC, et al. Juvenile nasopharyngeal angiofibromas in Denmark 1981–2003: diagnosis, incidence, and treatment. Acta Otolaryngol 2007;127:292–9.
116. MoulinG, ChagnaudC, GrasR, et al. Juvenile nasopharyngeal angiofibroma: comparison of blood loss during removal in embolized group versus nonembolized group. Cardiovasc Intervent Radiol 1995;18:158–61.
117. OueslatiS, GamraOB, KharratS, et al. [nasopharyngeal angiofibroma: report of 15 cases treated by embolization]. J Radiol 2008;89:579–84.
118. FonsecaAS, VinhaesE, BoaventuraV, et al. Surgical treatment of non-embolized patients with nasoangiofibroma. Braz J Otorhinolaryngol 2008;74:583–7.
119. El-BanhawyOA, RagabA, El-SharnobyMM. Surgical resection of type iii juvenile angiofibroma without preoperative embolization. Int J Pediatr Otorhinolaryngol 2006;70:1715–23.
120. SchickB, KahleG. Radiological findings in angiofibroma. Acta Radiol 2000;41:585–93.
121. LiJR, QianJ, ShanXZ, WangL. Evaluation of the effectiveness of preoperative embolization in surgery for nasopharyngeal angiofibroma. Eur Arch Otorhinolaryngol 1998;255:430–2.
122. SiniluotoTM, LuotonenJP, TikkakoskiTA, LeinonenAS, JokinenKE. Value of pre-operative embolization in surgery for nasopharyngeal angiofibroma. J Laryngol Otol 1993;107:514–21.
123. ZhangM, GarvisW, LinderT, FischU. Update on the infratemporal fossa approaches to nasopharyngeal angiofibroma. Laryngoscope 1998;108:1717–23.
124. PetrusonK, Rodriguez-CatarinoM, PetrusonB, FiniziaC. Juvenile nasopharyngeal angiofibroma: long-term results in preoperative embolized and non-embolized patients. Acta Otolaryngol 2002;122:96–100.
125. Qureshiai, a new classification scheme based on angiographic arterial supply to neoplasms. J Vasc Interv Neurol 2009;2:153–4.
126. KawaiK, YoshinagaK, KoizumiM, HonmaS, TokiyoshiA, KodamaK. A middle meningeal artery which arises from the internal carotid artery in which the first branchial artery participates. Ann Anat 2006;188:33–8.
127. ShimaH, von LuedinghausenM, OhnoK, MichiK. Anatomy of microvascular anastomosis in the neck. Plast Reconstr Surg 1998;101:33–41.
128. ProbstEN, GrzyskaU, WestphalM, ZeumerH. Preoperative embolization of intracranial meningiomas with a fibrin glue preparation. Am J Neuroradiol 1999;20:1695–702.
129. NgSH, WanYL, WongHF, et al. Preoperative embolization of meningiomas: Comparison of superselective and subselective techniques. J Formos Med Assoc. 1998;97:153–158.
130. HayashiN, KuboM, TsuboiY, et al. Impact of anomalous origin of the ophthalmic artery from the middle meningeal artery on selection of surgical approach to skull base meningioma. Surg Neurol 2007;68:568–571; discussion 571–2.
131. OhataK, NishioA, TakamiT, GotoT. Sudden appearance of transdural anastomosis from middle meningeal artery to superior cerebellar artery during preoperative embolization of meningioma. Neurol India 2006;54:328.
132. MaiuriF, DonzelliR, de DivitiisO, FuscoM, BrigantiF. Anomalous meningeal branches of the ophthalmic artery feeding meningiomas of the brain convexity. Surg Radiol Anat 1998;20:279–84.
133. SpetzlerRF, ModicM, BonstelleC. Spontaneous opening of large occipital-vertebral artery anastomosis during embolization. Case report. J Neurosurg 1980;53:849–50.
134. KendallB, MoseleyI. Therapeutic embolisation of the external carotid arterial tree. J Neurol Neurosurg Psychiatry 1977;40:937–50.
135. KaiY, HamadaJ, MoriokaM, et al. Preoperative cellulose porous beads for therapeutic embolization of meningioma: provocation test and technical considerations. Neuroradiology 2007;49:437–43.
136. SerbinenkoFA, LysachevAG, ArustamianSR. [main anastomoses of external carotid artery branches with the beds of the internal carotid and the vertebral artery and a role of pharmacological tests in the determination of their functional value at tumor embolization]. Zh Vopr Neirokhir Im N N Burdenko 2002:15–18.
137. HiraiT, KorogiY, OnoK, UemuraS, YamashitaY. Preoperative embolization for meningeal tumors: Evaluation of vascular supply with angio-ct. Am J Neuroradiol 2004;25:74–6.
138. LaurentA, WassefM, ChapotR, HoudartE, MerlandJJ. Location of vessel occlusion of calibrated tris-acryl gelatin microspheres for tumor and arteriovenous malformation embolization. J Vasc Interv Radiol 2004;15:491–6.
139. WakhlooAK, JuenglingFD, Van VelthovenV, SchumacherM, HennigJ, SchwechheimerK. Extended preoperative polyvinyl alcohol microembolization of intracranial meningiomas: Assessment of two embolization techniques. Am J Neuroradiol 1993;14:571–82.
140. BendszusM, KleinR, BurgerR, Warmuth-MetzM, HofmannE, SolymosiL. Efficacy of trisacryl gelatin microspheres versus polyvinyl alcohol particles in the preoperative embolization of meningiomas. Am J Neuroradiol 2000;21:255–61.
141. LaurentA, WassefM, ChapotR, et al. Partition of calibrated tris-acryl gelatin microspheres in the arterial vasculature of embolized nasopharyngeal angiofibromas and paragangliomas. J Vasc Interv Radiol 2005;16:507–13.
142. DerdeynCP, MoranCJ, CrossDT, DietrichHH, DaceyRG, Jr. Polyvinyl alcohol particle size and suspension characteristics. Am J Neuroradiol 1995;16:1335–43.
143. YoonYS, AhnJY, ChangJH, ChoJH, SuhSH, LeeBH, LeeKS. Pre-operative embolisation of internal carotid artery branches and pial vessels in hypervascular brain tumours. Acta Neurochir (Wien) 2008;150:447–52; discussion 452.
144. KajiT, HamaY, IwasakiY, KyotoY, KusanoS. Preoperative embolization of meningiomas with pial supply: successful treatment of two cases. Surg Neurol 1999;52:270–3.
145. LiangY, WangD, HuangW, LingF, LiuY, LuF. Direct intratumoral embolization of hypervascular tumors of the head and neck. Chin Med J (Engl) 2003;116:616–19.
146. PierotL, BoulinA, CastaingsL, ChabolleF, MoretJ. [embolization by direct puncture of hypervascularized orl tumors]. Ann Otolaryngol Chir Cervicofac 1994;111:403–9.
147. CasascoA, HoudartE, BiondiA, et al. Major complications of percutaneous embolization of skull-base tumors. Am J Neuroradiol 1999;20:179–81.
148. CasascoA, HerbreteauD, HoudartE, et al. Devascularization of craniofacial tumors by percutaneous tumor puncture. Am J Neuroradiol 1994;15:1233–9.
149. GobinYP, PascoA, MerlandJJ, AymardAA, CasascoA, HoudartE. Percutaneous puncture of the external carotid artery or its branches after surgical ligation. Am J Neuroradiol 1994;15:79–82.
150. SchrothG, HaldemannAR, MarianiL, RemondaL, RavehJ. Preoperative embolization of paragangliomas and angiofibromas. Measurement of intratumoral arteriovenous shunts. Arch Otolaryngol Head Neck Surg 1996;122:1320–5.
151. HorowitzMB, CarrauR, CrammondD, KanalE. Risks of tumor embolization in the presence of an unrecognized patent foramen ovale: Case report. Am J Neuroradiol 2002;23:982–4.
152. BentsonJ, RandR, CalcaterraT, LasjauniasP. Unexpected complications following therapeutic embolization. Neuroradiology 1978;16:420–3.
153. GuptaAK, PurkayasthaS, BodheyNK, KapilamoorthyTR, KesavadasC. Preoperative embolization of hypervascular head and neck tumours. Australas Radiol 2007;51:446–52.
154. ShiZS, FengL, JiangXB, HuangQ, YangZ, HuangZS. Therapeutic embolization of meningiomas with onyx for delayed surgical resection. Surg Neurol 2008;70:478–81.
155. KuboM, KuwayamaN, HirashimaY, TakakuA, OgawaT, EndoS. Hydroxyapatite ceramics as a particulate embolic material: Report of the clinical experience. Am J Neuroradiol 2003;24:1545–7.
156. KasuyaH, ShimizuT, SasaharaA, TakakuraK. Phenytoin as a liquid material for embolisation of tumours. Neuroradiology 1999;41:320–3.
157. FengL, KienitzBA, MatsumotoC, et al. Feasibility of using hyperosmolar mannitol as a liquid tumor embolization agent. Am J Neuroradiol 2005;26:1405–12.
158. LuoCB, TengMM, ChangFC, ChangCY, GuoWY. Radiation carotid blowout syndrome in nasopharyngeal carcinoma: Angiographic features and endovascular management. Otolaryngol Head Neck Surg 2008;138:86–91.
159. ScottCB, ScarantinoC, UrtasunR, et al. Validation and predictive power of radiation therapy oncology group (rtog) recursive partitioning analysis classes for malignant glioma patients: a report using rtog 90–06. Int J Radiat Oncol Biol Phys 1998;40:51–5.
160. DesjardinsA, ReardonDA, VredenburghJJ. Current available therapies and future directions in the treatment of malignant gliomas. Biologics 2009;3:15–25.
161. NakashimaM, ShibataS, TokunagaY, et al. In-vivo microdialysis study of the distribution of cisplatin into brain tumour tissue after intracarotid infusion in rats with 9l malignant glioma. J Pharm Pharmacol 1997;49:777–80.
162. TakedaN, DiksicM. Relationship between drug delivery and the intra-arterial infusion rate of sarcnu in c6 rat brain tumor model. J Neurooncol 1999;41:235–46.
163. NewtonHB. Intra-arterial chemotherapy of primary brain tumors. Curr Treat Options Oncol 2005;6:519–30.
164. GinosJZ, CooperAJ, DhawanV, et al. [13n]cisplatin pet to assess pharmacokinetics of intra-arterial versus intravenous chemotherapy for malignant brain tumors. J Nucl Med 1987;28:1844–52.
165. LevinVA, KabraPM, Freeman-DoveMA. Pharmacokinetics of intracarotid artery 14c-bcnu in the squirrel monkey. J Neurosurg 1978;48:587–93.
166. NambaH, KobayashiS, IwadateY, et al. Assessment of the brain areas perfused by superselective intra-arterial chemotherapy using single photon emission computed tomography with technetium-99m-hexamethyl-propyleneamine oxime–technical note. Neurol Med Chir (Tokyo) 1994;34:832–5.
167. BassoU, LonardiS, BrandesAA. Is intra-arterial chemotherapy useful in high-grade gliomas?Expert Rev Anticancer Ther 2002;2:507–19.
168. DeferG, FauchonF, SchaisonM, ChirasJ, BrunetP. Visual toxicity following intra-arterial chemotherapy with hydroxyethyl-cnu in patients with malignant gliomas. A prospective study with statistical analysis. Neuroradiology 1991;33:432–7.
169. ShapiroWR, GreenSB, BurgerPC, et al. A randomized comparison of intra-arterial versus intravenous bcnu, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma. J Neurosurg 1992;76:772–81.
170. StewartDJ, GrahovacZ, RusselNA, et al. Phase i study of intracarotid pcnu. J Neurooncol 1987;5:245–50.
171. NewtonHB, PageMA, JunckL, GreenbergHS. Intra-arterial cisplatin for the treatment of malignant gliomas. J Neurooncol 1989;7:39–45.
172. StewartDJ, WallaceS, FeunL, et al. A phase i study of intracarotid artery infusion of cis-diamminedichloroplatinum(ii) in patients with recurrent malignant intracerebral tumors. Cancer Res 1982;42:2059–62.
173. MaieseK, WalkerRW, GarganR, VictorJD. Intra-arterial cisplatin–associated optic and otic toxicity. Arch Neurol 1992;49:83–6.
174. TfayliA, HentschelP, MadajewiczS, et al. Toxicities related to intraarterial infusion of cisplatin and etoposide in patients with brain tumors. J Neurooncol 1999;42:73–7.
175. GoRS, AdjeiAA. Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin. J Clin Oncol 1999;17:409–22.
176. MurryDJ. Comparative clinical pharmacology of cisplatin and carboplatin. Pharmacotherapy 1997;17:140S–5S.
177. AlbertsDS. Carboplatin versus cisplatin in ovarian cancer. Semin Oncol 1995;22:88–90.
178. RuckdeschelJC. The future role of carboplatin. Semin Oncol 1994;21:114–18.
179. CloughesyTF, GobinYP, BlackKL, et al. Intra-arterial carboplatin chemotherapy for brain tumors: a dose escalation study based on cerebral blood flow. J Neurooncol 1997;35:121–31.
180. FollezouJY, FauchonF, ChirasJ. Intraarterial infusion of carboplatin in the treatment of malignant gliomas: a phase ii study. Neoplasma. 1989;36:349–52.
181. QureshiAI, SuriMF, KhanJ, et al. Superselective intra-arterial carboplatin for treatment of intracranial neoplasms: experience in 100 procedures. J Neurooncol 2001;51:151–8.
182. StewartDJ, BelangerJM, GrahovacZ, et al. Phase i study of intracarotid administration of carboplatin. Neurosurgery 1992;30:512–16; discussion 516–17.
183. BonstelleCT, KoriSH, RekateH. Intracarotid chemotherapy of glioblastoma after induced blood–brain barrier disruption. Am J Neuroradiol 1983;4:810–12.
184. FenstermacherJ, GazendamJ. Intra-arterial infusions of drugs and hyperosmotic solutions as ways of enhancing cns chemotherapy. Cancer Treat Rep 1981;65 Suppl 2:27–37.
185. InamuraT, NomuraT, BartusRT, BlackKL. Intracarotid infusion of rmp-7, a bradykinin analog: A method for selective drug delivery to brain tumors. J Neurosurg 1994;81:752–8.
186. MatsukadoK, InamuraT, NakanoS, FukuiM, BartusRT, BlackKL. Enhanced tumor uptake of carboplatin and survival in glioma-bearing rats by intracarotid infusion of bradykinin analog, rmp-7. Neurosurgery 1996;39:125–133; discussion 133–4.
187. GreenbergHS, EnsmingerWD, ChandlerWF, et al. Intra-arterial bcnu chemotherapy for treatment of malignant gliomas of the central nervous system. J Neurosurg 1984;61:423–9.
188. HochbergFH, PruittAA, BeckDO, DeBrunG, DavisK. The rationale and methodology for intra-arterial chemotherapy with bcnu as treatment for glioblastoma. J Neurosurg 1985;63:876–80.
189. BradacGB, SoffiettiR, RivaA, SturaG, SalesS, SchifferD. Selective intra-arterial chemotherapy with bcnu in recurrent malignant gliomas. Neuroradiology 1992;34:73–6.
190. VegaF, DavilaL, ChatellierG, et al. Treatment of malignant gliomas with surgery, intraarterial chemotherapy with acnu and radiation therapy. J Neurooncol 1992;13:131–5.
191. BoboH, KappJP, VanceR. Effect of intra-arterial cisplatin and 1,3-bis(2chloroethyl)-1-nitrosourea (bcnu) dosage on radiographic response and regional toxicity in malignant glioma patients: proposal of a new method of intra-arterial dosage calculation. J Neurooncol 1992;13:291–9.
192. StewartDJ, GrahovacZ, HugenholtzH, et al. Feasibility study of intraarterial vs intravenous cisplatin, bcnu, and teniposide combined with systemic cisplatin, teniposide, cytosine arabinoside, glycerol and mannitol in the treatment of primary and metastatic brain tumors. J Neurooncol 1993;17:71–9.
193. HiranoY, MineuraK, MizoiK, TomuraN. Therapeutic results of intra-arterial chemotherapy in patients with malignant glioma. Int J Oncol 1998;13:537–42.
194. PaccapeloA, PianaC, RychlickiF, et al. Treatment of malignant gliomas: a new approach. Tumori. 1998;84:529–33.
195. BashirR, HochbergFH, LinggoodRM, HottlemanK. Pre-irradiation internal carotid artery bcnu in treatment of glioblastoma multiforme. J Neurosurg 1988;68:917–19.
196. FauchonF, DavilaL, ChatellierG, et al. Treatment of malignant gliomas with surgery, intra-arterial infusions of 1-(2-hydroxyethyl)chloroethylnitrosourea, and radiation therapy: A phase ii study. Neurosurgery 1990;27:231–4.
197. IwadateY, NambaH, SaegusaT, SueyoshiK. Intra-arterial mannitol infusion in the chemotherapy for malignant brain tumors. J Neurooncol 1993;15:185–93.
198. KochiiM, KitamuraI, GotoT, et al. Randomized comparison of intra-arterial versus intravenous infusion of acnu for newly diagnosed patients with glioblastoma. J Neurooncol 2000;49:63–70.
199. FeunLG, WallaceS, StewartDJ, et al. Intracarotid infusion of cis-diamminedichloroplatinum in the treatment of recurrent malignant brain tumors. Cancer 1984;54:794–9.
200. NeuweltEA, HowiesonJ, FrenkelEP, et al. Therapeutic efficacy of multiagent chemotherapy with drug delivery enhancement by blood–brain barrier modification in glioblastoma. Neurosurgery. 1986;19:573–82.
201. MahaleyMS, Jr., HippSW, DropchoEJ, et al. Intracarotid cisplatin chemotherapy for recurrent gliomas. J Neurosurg. 1989;70:371–8.
202. SarisSC, BlasbergRG, CarsonRE, et al. Intravascular streaming during carotid artery infusions. Demonstration in humans and reduction using diastole-phased pulsatile administration. J Neurosurg 1991;74:763–72.
203. TamakiM, OhnoK, NiimiY, et al. Parenchymal damage in the territory of the anterior choroidal artery following supraophthalmic intracarotid administration of cddp for treatment of malignant gliomas. J Neurooncol 1997;35:65–72.
204. DropchoEJ, RosenfeldSS, VitekJ, GuthrieBL, MorawetzRB. Phase ii study of intracarotid or selective intracerebral infusion of cisplatin for treatment of recurrent anaplastic gliomas. J Neurooncol 1998;36:191–8.
205. AshbyLS, ShapiroWR. Intra-arterial cisplatin plus oral etoposide for the treatment of recurrent malignant glioma: A phase ii study. J Neurooncol 2001;51:67–86.
206. RechtL, FramRJ, StraussG, et al. Preirradiation chemotherapy of supratentorial malignant primary brain tumors with intracarotid cis-platinum (cddp) and i.V. Bcnu. A phase ii trial. Am J Clin Oncol 1990;13:125–31.
207. MadajewiczS, ChowhanN, TfayliA, et al. Therapy for patients with high grade astrocytoma using intraarterial chemotherapy and radiation therapy. Cancer 2000;88:2350–6.
208. LarnerJM, KershCR, ConstableWC, et al. Phase i/ii trial of superselective arterial 5-fu infusion with concomitant external beam radiation for patients with either anaplastic astrocytoma or glioblastoma multiforme. Am J Clin Oncol 1991;14:514–18.
209. DropchoEJ, RosenfeldSS, MorawetzRB, et al. Preradiation intracarotid cisplatin treatment of newly diagnosed anaplastic gliomas. The cns cancer consortium. J Clin Oncol 1992;10:452–8.
210. DoolittleND, MinerME, HallWA, et al. Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors. Cancer 2000;88:637–47.
211. BlackKL, CloughesyT, HuangSC, et al. Intracarotid infusion of rmp-7, a bradykinin analog, and transport of gallium-68 ethylenediamine tetraacetic acid into human gliomas. J Neurosurg 1997;86:603–9.
212. GregorA, LindM, NewmanH, et al. Phase ii studies of rmp-7 and carboplatin in the treatment of recurrent high grade glioma. Rmp-7 european study group. J Neurooncol 1999;44:137–45.
213. LeMayDR, KittakaM, GordonEM, et al. Intravenous rmp-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy. Hum Gene Ther 1998;9:989–95.
214. ImbesiF, MarchioniE, BenericettiE, et al. A randomized phase iii study: Comparison between intravenous and intraarterial acnu administration in newly diagnosed primary glioblastomas. Anticancer Res 2006;26:553–8.
215. KirbyS, BrothersM, IrishW, et al. Evaluating glioma therapies: Modeling treatments and predicting outcomes. J Natl Cancer Inst 1995;87:1884–8.
216. HiesigerEM, GreenSB, ShapiroWR, et al. Results of a randomized trial comparing intra-arterial cisplatin and intravenous pcnu for the treatment of primary brain tumors in adults: Brain tumor cooperative group trial 8420a. J Neurooncol 1995;25:143–54.
217. DurandRE. Synergism of cisplatin and mitomycin c in sensitive and resistant cell subpopulations of a tumor model. Int J Cancer 1989;44:911–17.
218. DurandRE. Cisplatin and ccnu synergism in spheroid cell subpopulations. Br J Cancer 1990;62:947–53.
219. PlowmanJ, WaudWR, KoutsoukosAD, RubinsteinLV, MooreTD, GreverMR. Preclinical antitumor activity of temozolomide in mice: Efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res 1994;54:3793–9.
220. RogersLR, PurvisJB, LedermanRJ, et al. Alternating sequential intracarotid bcnu and cisplatin in recurrent malignant glioma. Cancer 1991;68:15–21.
221. FeunLG, WallaceS, YungWK, et al. Phase-i trial of intracarotid bcnu and cisplatin in patients with malignant intracerebral tumors. Cancer Drug Deliv 1984;1:239–45.
222. FeunLG, LeeYY, YungWK, et al. Phase ii trial of intracarotid bcnu and cisplatin in primary malignant brain tumors. Cancer Drug Deliv 1986;3:147–56.
223. ChauveincL, Sola-MartinezMT, Martin-DuverneuilM, et al. Intra arterial chemotherapy with acnu and radiotherapy in inoperable malignant gliomas. J Neurooncol 1996;27:141–7.
224. AngelovL, DoolittleND, KraemerDF, et al. Blood–brain barrier disruption and intra-arterial methotrexate-based therapy for newly diagnosed primary cns lymphoma: a multi-institutional experience. J Clin Oncol 2009;27:3503–9.
225. TysonRM, SiegalT, DoolittleND, LacyC, KraemerDF, NeutweltEA. Current status and future of relapsed primary central nervous system lymphoma (pcnsl). Leuk Lymphoma 2003;44:627–33.
226. StewartDJ, GrahovacZ, BenoitB, et al. Intracarotid chemotherapy with a combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (bcnu), cis-diaminedichloroplatinum (cisplatin), and 4′-o-demethyl-1-o-(4,6-o-2-thenylidene-beta-d-glucopyranosyl) epipodophyllotoxin (vm-26) in the treatment of primary and metastatic brain tumors. Neurosurgery 1984;15:828–33.
227. StewartLA. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 2002;359:1011–18.
228. TsaoMN, MehtaMP, WhelanTJ, et al. The american society for therapeutic radiology and oncology (astro) evidence-based review of the role of radiosurgery for malignant glioma. Int J Radiat Oncol Biol Phys 2005;63:47–55.
229. StuppR, HegiME, MasonWP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase iii study: 5-year analysis of the eortc-ncic trial. Lancet Oncol 2009;10:459–66.
230. BalmAJ, RaschCR, SchornagelJH, et al. High-dose superselective intra-arterial cisplatin and concomitant radiation (radplat) for advanced head and neck cancer. Head Neck 2004;26:485–93.
231. HommaA, FurutaY, SuzukiF, et al. Rapid superselective high-dose cisplatin infusion with concomitant radiotherapy for advanced head and neck cancer. Head Neck 2005;27:65–71.
232. WatneK, HannisdalE, NomeO, HagerB, HirschbergH. Prognostic factors in malignant gliomas with special reference to intra-arterial chemotherapy. Acta Oncol 1993;32:307–10.
233. WatneK, HannisdalE, NomeO, et al. Combined intra-arterial chemotherapy followed by radiation in astrocytomas. J Neurooncol 1992;14:73–80.
234. SiegalT, RubinsteinR, BoksteinF, et al. In vivo assessment of the window of barrier opening after osmotic blood–brain barrier disruption in humans. J Neurosurg 2000;92:599–605.
235. ThomasHD, LindMJ, FordJ, BleehenN, CalvertAH, BoddyAV. Pharmacokinetics of carboplatin administered in combination with the bradykinin agonist cereport (rmp-7) for the treatment of brain tumours. Cancer Chemother Pharmacol 2000;45:284–90.
236. KupersmithMJ, FrohmanLP, ChoiIS, et al. Visual system toxicity following intra-arterial chemotherapy. Neurology 1988;38:284–9.
237. StewartDJ, GrahovacZ, HugenholtzH, RussellN, RichardM, BenoitB. Combined intraarterial and systemic chemotherapy for intracerebral tumors. Neurosurgery 1987;21:207–14.
238. BlacklockJB, WrightDC, DedrickRL, et al. Drug streaming during intra-arterial chemotherapy. J Neurosurg 1986;64:284–91.
239. GobinYP, CloughesyTF, ChowKL, et al. Intraarterial chemotherapy for brain tumors by using a spatial dose fractionation algorithm and pulsatile delivery. Radiology 2001;218:724–32.
240. NakagawaH, FujitaT, KuboS, et al. Selective intra-arterial chemotherapy with a combination of etoposide and cisplatin for malignant gliomas: preliminary report. Surg Neurol 1994;41:19–27.
241. OldfieldEH, DedrickRL, et al. Reduced systemic drug exposure by combining intra-arterial chemotherapy with hemoperfusion of regional venous drainage. J Neurosurg 1985;63:726–32.
242. MillerAB, HoogstratenB, StaquetM, WinklerA. Reporting results of cancer treatment. Cancer 1981;47:207–14.
243. KarnofskyDA, BurchenalJH. The clinical evaluation of chemotherapeutic agents in cancer. In MacleodCM, ed. Evaluation of Chemotherapeutic Agents. New York: Columbia Press, 1949, 191–205.
244. LangenKJ, RoosenN, KuwertT, et al. Early effects of intra-arterial chemotherapy in patients with brain tumours studied with pet: Preliminary results. Nucl Med Commun 1989;10:779–90.
245. ChowKL, GobinYP, CloughesyT, SayreJW, VillablancaJP, VinuelaF. Prognostic factors in recurrent glioblastoma multiforme and anaplastic astrocytoma treated with selective intra-arterial chemotherapy. Am J Neuroradiol 2000;21:471–8.
246. CortazarP, JohnsonBE. Review of the efficacy of individualized chemotherapy selected by in vitro drug sensitivity testing for patients with cancer. J Clin Oncol 1999;17:1625–31.
247. IwadateY, FujimotoS, NambaH, YamauraA. Promising survival for patients with glioblastoma multiforme treated with individualised chemotherapy based on in vitro drug sensitivity testing. Br J Cancer 2003;89:1896–900.
248. GelmanM, ChakeresDW, NewtonHB. Brain tumors: Complications of cerebral angiography accompanied by intraarterial chemotherapy. Radiology 1999;213:135–40.
249. GemmeteJJ. Complications associated with selective high-dose intraarterial cisplatin and concomitant radiation therapy for advanced head and neck cancer. J Vasc Interv Radiol 2003;14:743–8.
250. JohannesenTB, LienHH, HoleKH, LoteK. Radiological and clinical assessment of long-term brain tumour survivors after radiotherapy. Radiother Oncol 2003;69:169–76.
251. WilliamsPC, HennerWD, Roman-GoldsteinS, et al. Toxicity and efficacy of carboplatin and etoposide in conjunction with disruption of the blood-brain tumor barrier in the treatment of intracranial neoplasms. Neurosurgery 1995;37:17–27; discussion 27–8.
252. NeuweltEA, BrummettRE, DoolittleND, et al. First evidence of otoprotection against carboplatin-induced hearing loss with a two-compartment system in patients with central nervous system malignancy using sodium thiosulfate. J Pharmacol Exp Ther 1998;286:77–84.
253. MoritaK, TanakaR, KakinumaK, TakahashiH, MotoyamaH. Combination therapy of rat brain tumours using localized interstitial hyperthermia and intra-arterial chemotherapy. Int J Hyperthermia 2003;19:204–12.
254. NewtonHB, SnyderMA, StevensC, et al. Intra-arterial carboplatin and intravenous etoposide for the treatment of brain metastases. J Neuro-Oncol 2003;61: 35–44.
255. NewtonHB, FiggGM, SloneW, BourekasE. Incidence of infusion plan alterations after angiography in patients undergoing intra-arterial chemotherapy for brain tumors. J Neuro-Oncol 2006;78;157–60.
256. BourekasEC, FiggGM, SloneW, NewtonHB: Incidence and complication rate of incidental aneurysms discovered during intra-arterial chemotherapy of brain tumors. Am J Neuroradiol 2006; 27;297–9.